•
Jun 30, 2024

Ascendis Pharma Q2 2024 Earnings Report

Total Revenue
$38.8M
Previous year: $51.7M
-25.0%
EPS
-$2.06
Previous year: -$2.35
-12.3%
Gross Profit
$24.3M
Cash and Equivalents
$277M
Free Cash Flow
-$66.1M
Total Assets
$813M

Ascendis Pharma

Ascendis Pharma